MedTrace Logo

A Prospective Study of a New Device for Monitoring Cerebral Oxygenation on Healthy Volunteers

NCT00598819 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2011-08-17

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether a new cerebral oxygen monitoring device is effective and comparatively similar to the current approved devices.

Conditions

  • Cerebral Ischemia

Interventions

DEVICE

CDI 1000 COM

CDI 1000 COM sensors were attached to subject's forehead for a 12 hour period.

Sponsors & Collaborators

  • University of California, Irvine

    lead OTHER

Principal Investigators

  • Jeffrey C Milliken, MD · University of California, Irvine

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2009-05-31
Completion
2009-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00598819 on ClinicalTrials.gov